AngieHolmes
Explorer
Are peptides pulling in more money than fentanyl? According to Wired magazine:
Chinese Crypto-Funded Fentanyl Labs Are Switching to Selling Peptides#-chinese-crypto-funded-fentanyl-labs-are-switching-to-selling-peptidesPeptides—amino acid chains marketed as supplements that claim to deliver benefits ranging from fat loss to younger-looking skin for anyone who rubs them on, swallows them, or injects them—have grown into a pharmaceutical subindustry of their own that is mostly unregulated. It makes sense, then, that crypto money, frequently wired straight to the Chinese labs behind these obscure cure-alls, is driving that expansion.
This week, Chainalysis, a firm that traces cryptocurrency transactions, released an analysis of crypto payments going to peptide vendors—a gray market the company now values at over $100 million per year, with no sign of slowing. Chainalysis pinpointed something notable: certain Chinese labs that used to move fentanyl precursors have pivoted to producing and selling peptides instead. In Chainalysis's view, that shift is meant to profit from the “looksmaxing” trend spreading through social media, which has boosted peptide demand—while sidestepping the danger of a law enforcement crackdown on opioid makers.
Chinese Crypto-Funded Fentanyl Labs Are Switching to Selling Peptides#-chinese-crypto-funded-fentanyl-labs-are-switching-to-selling-peptidesPeptides—amino acid chains marketed as supplements that claim to deliver benefits ranging from fat loss to younger-looking skin for anyone who rubs them on, swallows them, or injects them—have grown into a pharmaceutical subindustry of their own that is mostly unregulated. It makes sense, then, that crypto money, frequently wired straight to the Chinese labs behind these obscure cure-alls, is driving that expansion.
This week, Chainalysis, a firm that traces cryptocurrency transactions, released an analysis of crypto payments going to peptide vendors—a gray market the company now values at over $100 million per year, with no sign of slowing. Chainalysis pinpointed something notable: certain Chinese labs that used to move fentanyl precursors have pivoted to producing and selling peptides instead. In Chainalysis's view, that shift is meant to profit from the “looksmaxing” trend spreading through social media, which has boosted peptide demand—while sidestepping the danger of a law enforcement crackdown on opioid makers.